title: PPADS is a reversible competitive antagonist of the NAADP receptor.
abstract: NAADP has been shown to act as a second messenger in a wide range of systems from plants to mammalian cells. Although it had always been considered as a canonical second messenger, recent work has shown that it is also active when applied extracellularly. It has also been suggested that NAADP might have a direct action on P2 receptors, based on the action of a pharmacological agent, PPADS, on Ca2+ signals in response to extracellular NAADP. We have therefore investigated whether PPADS can act directly on the intracellular NAADP-induced Ca2+-release system in the well characterised sea urchin egg homogenate system. Indeed, PPADS, and its structural analogue PPNDS were able to compete with [32P]NAADP for the binding site and binding curves revealed that both compounds display affinities in the low micromolar range. The binding of PPADS was reversible in contrast to that of NAADP. In fluorimetric Ca2+-release experiments, PPADS was able to competitively antagonise NAADP-induced Ca2+-release with an IC50 of 20 microM, while it did not affect the other Ca2+-release channels. This is the first report of a reversible, competitive antagonist of the sea urchin NAADP receptor. Furthermore, PPADS might reveal itself as an invaluable tool to investigate NAADP signalling and is a lead compound for the synthesis of potent and specific antagonists.
authors.affiliation: DiSCAFF and the DFB Centre, Universita' del Piemonte Orientale, Via Bovio 6, 28100 Novara, Italy. billington@pharm.unipmn.it
authors.forename: Richard A
authors.initials: RA
authors.lastname: Billington
authors.forename: Armando A
authors.initials: AA
authors.lastname: Genazzani
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000187:drug effects*; D020013:Calcium Signaling / Q000187:drug effects; D005260:Female; D005470:Fluorometry; D009249:NADP / Q000031:analogs & derivatives* / Q000378:metabolism; D010063:Ovum; D011725:Pyridines; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D011869:Radioligand Assay; D018048:Receptors, Purinergic P2 / Q000378:metabolism*; D012617:Sea Urchins; D013451:Sulfonic Acids / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D015220:Calcium Channels; D011725:Pyridines; D018048:Receptors, Purinergic P2; D013451:Sulfonic Acids; C405633:pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate); C077792:pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid; D009249:NADP; C024376:NAADP; D011732:Pyridoxal Phosphate; D002118:Calcium